Randomized Double-Blind Placebo-Controlled Trial of Desmopressin for Post–Kidney Biopsy Bleeding
Desmopressin effectively reduces postbiopsy bleeding and hematoma formation with manageable side effects, supporting its role as a prophylactic option in kidney biopsies. Further studies are needed to confirm its broader clinical applications.
Authors
- Manas Ranjan Behera (ORCID: https://orcid.org/0000-0003-4785-5949)
- Verma Anupam
- Jeyakumar Meyyappan (ORCID: https://orcid.org/0000-0002-4625-1169)
- Dheeraj Khetan
- Jai Kishun (ORCID: https://orcid.org/0000-0001-7778-4446)
- Monika Yachha
- Manas Ranjan Patel (ORCID: https://orcid.org/0000-0002-2353-3171)
- Vamsidhar Veeranki (ORCID: https://orcid.org/0000-0002-7446-281X)
- Dharmendra Bhadauria (ORCID: https://orcid.org/0000-0002-1273-8294)
- Deependra Kumar Yadav
- Anupama Kaul
- Ravi Kushwaha
- Heera Lal
- Narayan Prasad (ORCID: https://orcid.org/0000-0002-3643-9459)
Institutions
- Sanjay Gandhi Post Graduate Institute of Medical Sciences (IN)
Publication Details
- Journal
- Kidney International Reports
- Published
- 2025-04-17
- DOI
- https://doi.org/10.1016/j.ekir.2025.04.019
- Citations
- 6
- Primary Topic
- Renal Diseases and Glomerulopathies
- Type
- article
- Field-Weighted Citation Impact
- 8.58
Funders
- Sanjay Gandhi Postgraduate Institute of Medical Sciences